Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / Germany

Boehringer Ingelheim In Good Health

April 2007 | Company Finance Alert

German drugmaker Boehringer Ingelheim (BI) has recorded net sales of EUR10.6bn (US$14.2bn) for the 2006 financial year, an increase of 11%, while operating income grew 11% to EUR2.1bn (US$2.8bn). The privately held company, which announced its results at its annual press conference, expects sales growth in 2007 to be in the high-single digits, beating the market.

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *


If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.

Western Europe InsightWestern Europe Channels Western Europe Countries